AACR Annual Meeting 2023 AACR 2023: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Adjuvant Durvalumab in Patients With Resectable NSCLC
Lung Cancer Wildfire-Dominated PM2.5 Exposure and Non–Small Cell Lung Cancer Survival in California
Genitourinary Cancers Radiopharmaceuticals for Treatment of Metastatic Castration-Resistant Prostate Cancer
